Business Context and Reporting Period
This Form 8-K Current Report is filed by Elevai Labs Inc. (trading symbol: ELAB) on November 20, 2024. The registrant is a Delaware corporation listed on The Nasdaq Capital Market. The report details a material corporate action regarding the company's capital structure.
Key Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes
- Reverse Stock Split: The Company filed a Certificate of Amendment to effect a 1-for-200 reverse stock split of its common stock, effective November 27, 2024.
- Share Reclassification: Every 200 shares of issued and outstanding common stock prior to the effective time will be reclassified into one share.
- Fractional Shares: No fractional shares were issued; stockholders entitled to a fractional share received one whole share in lieu thereof.
- Trading Adjustments: The stock will trade on a split-adjusted basis on November 27, 2024, under the same symbol "ELAB" but with a new CUSIP number (28622K 203).
- Equity Plan Adjustments: The number of shares available for future grants and the terms of outstanding stock options (including exercise prices) have been adjusted to reflect the split.
Outlook, Risks, and Management Commentary
Purpose of Action: The reverse stock split is being executed to achieve compliance with Nasdaq Listing Rule 5550(a)(2), which mandates a minimum closing bid price of $1.00 per share for continued listing.
Approval History: The split was approved by stockholders on August 12, 2024, within a range of 1-for-2 to 1-for-200. The Board of Directors subsequently approved the specific 1-for-200 ratio on August 22, 2024.
Administrative Details: VStock Transfer, LLC is acting as the exchange agent. Stockholders holding shares in brokerage accounts ("street name") do not need to take action, while those holding physical certificates will receive instructions.
Investor Verification Checklist
- Verify the effective date of the reverse stock split is November 27, 2024.
- Confirm the new CUSIP number for the stock is 28622K 203.
- Check brokerage account statements to ensure holdings have been adjusted to the 1-for-200 ratio.
- Review the adjusted exercise prices of any outstanding stock options held.
- Monitor the stock price post-split to ensure it meets the $1.00 minimum bid price requirement for Nasdaq compliance.